SHPH Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Shuttle Pharmaceuticals Holdings Inc (SHPH) is not a strong buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock exhibits overbought technical indicators, weak financial performance, and lacks positive catalysts or significant trading trends. Given the absence of compelling growth signals or influential endorsements, it is better to hold off on investing in this stock at this time.
The MACD is positive and expanding, indicating bullish momentum. However, the RSI is at 81.118, signaling an overbought condition. Moving averages are converging, suggesting indecision in price direction. The pre-market price of $1.03 is near the resistance level of R1 ($1.086), limiting immediate upside potential.
NULL identified. No recent news or significant trading trends from hedge funds or insiders.
Overbought RSI suggests potential for a price pullback. Weak financial performance with negative net income and declining EPS.
In Q4 2025, revenue remained at $0 with no growth. Net income improved YoY but remains negative at -$2,614,895. EPS dropped significantly by -93.25% YoY, indicating poor profitability.
No analyst rating or price target data available.
